Nimesulide-SZ, 100 mg 2 g 10 pcs

Non-steroidal anti-inflammatory drugs (NSAIDs)

ATX code: M01AX17

Pharmacodynamics

Nimesulide is a non-steroidal anti-inflammatory drug of the sulfonamide class. It has anti-inflammatory, analgesic and antipyretic effect. Unlike non-selective NSAIDs, nimesulide mainly inhibits cyclooxygenase-2 (COX-2), inhibits synthesis of prostaglandins in inflammation focus, has less pronounced inhibitory effect on cyclooxygenase-1 (COX-1).

Pharmacokinetics

Nimesulide is well absorbed from the gastrointestinal tract (GIT)

Maximal concentration in blood plasma (Stah) after oral administration of a single dose of nimesulide, 100 mg, is reached on average after 2-3 hours and is 3-4 mg/l. The area under the curve “concentration-time” (AUC) is 20-35 mg/hl.

Binding with blood plasma proteins is up to 97.5%.

Metabolized in the liver by cytochrome Р450 isoenzyme (CYP)2C9. The main metabolite is pharmacologically active parahydroxy derivative of nimesulide – hydroxynimesulide, which is found only as glucuronate.

Nimesulide is excreted mainly with urine (about 50% of the dose taken), about 29% is metabolized with feces.

The half-life (T1/2) is 3.2-6 hours.

Pharmacokinetic profile of nimesulide in elderly patients and in patients with renal insufficiency of mild and moderate severity is not changed by using single and multiple/repeated doses.

In a study conducted in patients with mild to moderate renal insufficiency (creatinine clearance 30-80 ml/min), the rates of nimesulide and its main metabolite were not higher than in healthy volunteers. AUC and Tj/2 were 50% higher, but were within the values of AUC and Tj/2 observed in healthy volunteers against the background of nimesulide use.

Repeated use did not lead to nimesulide cumulation.

Indications

Active ingredient

Composition

How to take, the dosage

Interaction

Special Instructions

Contraindications

Side effects

Overdose

Pregnancy use

Similarities